Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Pfefferle

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancers|March 21, 2020
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer TherapyAline Pfefferle, Nicholas D Huntington
Cancer Cell|September 19, 2025
Rewiring natural killer cells for next-generation cancer therapiesAline Pfefferle, Karl-Johan Malmberg
Biochimica Et Biophysica Acta|October 17, 2012
Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeuticsAline Pfefferle, Ryan J Mailloux, Cyril Nii-Klu Adjeitey, et al.
Frontiers in Immunology|June 2, 2020
Deciphering Natural Killer Cell HomeostasisAline Pfefferle, Benedikt Jacobs, Alvaro Haroun-Izquierdo, et al.
Oncotarget|October 27, 2015
Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndromeEbba Sohlberg, Aline Pfefferle, Sandra Andersson, et al.
BMJ Open|July 22, 2024
Association between continuity of care and inappropriate prescribing in outpatient care in Germany: a cross-sectional analysis conducted as part of the LoChro trialAline Pfefferle, Nadine Binder, Julia Sauer, et al.
Cancer Immunology Research|August 20, 2021
The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient OutcomeMomeneh Foroutan, Ramyar Molania, Aline Pfefferle, et al.
BMC Geriatrics|July 7, 2022
Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany - a cross-sectional survey conducted as part of a randomised comparative effectiveness trialClaudia Salm, Julia Sauer, Nadine Binder, et al.
Molecular Oncology|November 26, 2015
Harnessing adaptive natural killer cells in cancer immunotherapyLisa L Liu, Aline Pfefferle, Vincent Oei Yi Sheng, et al.
Cell Reports|November 21, 2019
Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire DiversityAline Pfefferle, Benedikt Jacobs, Herman Netskar, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|March 21, 2020
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer TherapyAline Pfefferle, Nicholas D Huntington
Cancer Cell|September 19, 2025
Rewiring natural killer cells for next-generation cancer therapiesAline Pfefferle, Karl-Johan Malmberg
Biochimica Et Biophysica Acta|October 17, 2012
Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeuticsAline Pfefferle, Ryan J Mailloux, Cyril Nii-Klu Adjeitey, et al.
Frontiers in Immunology|June 2, 2020
Deciphering Natural Killer Cell HomeostasisAline Pfefferle, Benedikt Jacobs, Alvaro Haroun-Izquierdo, et al.
Oncotarget|October 27, 2015
Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndromeEbba Sohlberg, Aline Pfefferle, Sandra Andersson, et al.
BMJ Open|July 22, 2024
Association between continuity of care and inappropriate prescribing in outpatient care in Germany: a cross-sectional analysis conducted as part of the LoChro trialAline Pfefferle, Nadine Binder, Julia Sauer, et al.
Cancer Immunology Research|August 20, 2021
The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient OutcomeMomeneh Foroutan, Ramyar Molania, Aline Pfefferle, et al.
BMC Geriatrics|July 7, 2022
Over- and under-prescribing, and their association with functional disability in older patients at risk of further decline in Germany - a cross-sectional survey conducted as part of a randomised comparative effectiveness trialClaudia Salm, Julia Sauer, Nadine Binder, et al.
Molecular Oncology|November 26, 2015
Harnessing adaptive natural killer cells in cancer immunotherapyLisa L Liu, Aline Pfefferle, Vincent Oei Yi Sheng, et al.
Cell Reports|November 21, 2019
Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire DiversityAline Pfefferle, Benedikt Jacobs, Herman Netskar, et al.
Pageof 3